BACKGROUND Total hip replacement provides pain relief and improves physical function and quality of life in patients with end-stage hip osteoarthritis. The incidence of hip replacement operations is expected to increase due to the growing elderly population. Overall, the posterior approach and lateral approach are the two most commonly used approaches for hip replacement operations. The posteri...

Objective We present a case report of complex regional pain syndrome (CRPS) type I following total hip replacement in a patient with insulin-dependent diabetes mellitus. Discussion CRPS type 1 as a primary complication following successful hip replacement surgery has not been reported before. We would suggest that CRPS may be a possible cause of persistent pain after successful total hip replac...

Since the introduction of total hip replacement arthroplasty in the United Stated in the early 1970s, this has become one of the most frequently performed and successful procedures available to the orthopaedic surgeon. It has revolutionized the treatment of patients with disorders of the hip. Excellent function can be achieved in over 95% of patients with minimal risk of complications. As a res...

OBJECTIVE To compare the health-related quality of life of people with osteoarthritis before and after primary total hip and knee replacement surgery with that of the general Australian population. DESIGN A prospective cohort study. SETTING Three Sydney hospitals, public and private. PARTICIPANTS Patients with osteoarthritis undergoing primary total hip (n = 59) and knee (n = 92) joint re...

OBJECTIVE To explore geographical and sociodemographic factors associated with variation in equity in access to total hip and knee replacement surgery. DESIGN Combining small area estimates of need and provision to explore equity in access to care. SETTING English census wards. SUBJECTS Patients throughout England who needed total hip or knee replacement and numbers who received surgery. ...

When Policy Topic is covered Metal-on-metal total hip resurfacing with a device system approved by the U.S. Food and Drug Administration (FDA) may be considered medically necessary as an alternative to total hip replacement when the patient:  Is a candidate for total hip replacement; AND  Is likely to outlive a traditional prosthesis; AND  Does not have a contraindication for total hip resur...

We evaluated 31 patients with bilateral dysplastic hips who had undergone periacetabular osteotomy for early (Tönnis grade 0 or 1) or moderate (Tönnis grade 2) osteoarthritis in one hip and total hip replacement for advanced (Tönnis grade 3) osteoarthritis in the other. At a mean follow-up of 5.5 years (2 to 9) after periacetabular osteotomy and 6.7 years (3 to 10) after total hip replacement, ...